Roy Chemaly, MD, MPH, FACP, FIDSA
Dr Roy Chemaly is a Professor of Medicine in the Department of Infectious Diseases, Infection Control & Employee Health at The University of Texas MD Anderson Cancer Center in Houston, Texas. Dr. Chemaly completed his training in infectious diseases and medical microbiology at the Cleveland Clinic Foundation in Ohio. He is board-certified in internal medicine/infectious diseases and medical microbiology.
During his fellowship, Dr. Chemaly completed a master’s degree in public health from Northeastern Ohio Universities in Rootstown, Ohio. He is also certified in health care delivery research, having successfully completed the Advanced Training Program in Health Care Delivery Research and Improvement provided by Intermountain Health Care Institute in Salt Lake City, Utah. Furthermore, Dr Chemaly is certified in Medical Quality after he successfully passed the American Board of Medical Quality exam in 2014.
In addition to Dr. Chemaly’s clinical research work in virology and multi-drug resistant organisms, he is the director of the Infection Control and the Antimicrobial Stewardship programs at MD Anderson Cancer Center. He also serves on many institutional committees, including the Infection Control Committee as the chair, Institutional Review Board as a vice chair, the Executive Committee of the Medical Staff, and the Patient Safety Committee. Dr. Chemaly also heads the Viral Protection Ad Hoc Infection Control Subcommittee as well as the Clinical Virology Research Program in the Department of Infectious Diseases as Director. Dr. Chemaly’s work has been reported in numerous peer-reviewed journals including New England Journal of Medicine, Blood, and Clinical Infectious Diseases. He was elected as a fellow of the American College of Physicians, the Infectious Diseases Society of America and was recently appointed as the chair of the Transplant Infectious Diseases Special Interest Group of the American Society of Bone Marrow Transplantation.